Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India · Delayed Price · Currency is INR 1,818.30
+11.60 (0.64%)
At close: Dec 4, 2025
NSE:SUNPHARMA Market Cap
NSE:SUNPHARMA has a market cap or net worth of 4.33 trillion as of December 4, 2025. Its market cap has increased by 1.56% in one year.
Market Cap
4.33T
Enterprise Value
4.11T
Revenue
549.64B
Ranking
n/a
PE Ratio
41.48
Stock Price
1,818.30
Market Cap Chart
Since February 15, 2001, NSE:SUNPHARMA's market cap has increased from 27.61B to 4.33T, an increase of 15,600.00%. That is a compound annual growth rate of 22.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 4.33T | -4.22% |
| Dec 31, 2024 | 4.53T | 49.78% |
| Dec 29, 2023 | 3.02T | 25.77% |
| Dec 30, 2022 | 2.40T | 18.41% |
| Dec 31, 2021 | 2.03T | 42.77% |
| Dec 31, 2020 | 1.42T | 36.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.70T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.05T |
| Zydus Lifesciences | 948.58B |
| Mankind Pharma | 920.37B |
| Aurobindo Pharma | 706.37B |
| Fortis Healthcare | 683.12B |
| Alkem Laboratories | 674.17B |